Wang Cecilia C Low, Goalstone Marc L, Draznin Boris
Research Service of the Denver Veterans Affairs Medical Center, Denver, CO, USA.
Diabetes. 2004 Nov;53(11):2735-40. doi: 10.2337/diabetes.53.11.2735.
Insulin resistance is concomitant with type 2 diabetes, obesity, hypertension, and other features of the metabolic syndrome. Because insulin resistance is associated with cardiovascular disease, both scientists and physicians have taken great interest in this disorder. Insulin resistance is associated with compensatory hyperinsulinemia, but individual contributions of either of these two conditions remain incompletely understood and a subject of intense investigation. One possibility is that in an attempt to overcome the inhibition within the metabolic insulin-signaling pathway, hyperinsulinemia may continue to stimulate the mitogenic insulin-signaling pathway, thus exerting its detrimental influence. Here we discuss some of the effects of insulin resistance and mechanisms of potentially detrimental influence of hyperinsulinemia in the presence of metabolic insulin resistance.
胰岛素抵抗与2型糖尿病、肥胖、高血压以及代谢综合征的其他特征相伴出现。由于胰岛素抵抗与心血管疾病相关,科学家和医生都对这种病症极为关注。胰岛素抵抗与代偿性高胰岛素血症相关,但这两种情况各自的具体作用仍未完全明确,仍是深入研究的课题。一种可能性是,为了克服代谢性胰岛素信号通路中的抑制作用,高胰岛素血症可能会持续刺激有丝分裂原性胰岛素信号通路,从而产生有害影响。在此,我们讨论胰岛素抵抗的一些影响以及在存在代谢性胰岛素抵抗的情况下高胰岛素血症潜在有害影响的机制。